Optimizing ixabepilone treatment schedules in patients with advanced or metastatic breast cancer

By Egerton Nancy  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1005-1012

Springer Publishing Company

Access to resources Recommend Favorite

Cisplatin, Methotrexate and Mitoxantrone in Patients with Metastatic or Advanced Urothelial Cancer

By Andersen Lisbeth J.   Sengeløv Lisa   Kamby Claus   von der Maase Hans  

Acta Oncologica, Vol. 37, Iss. 1, 1998-05 ,pp. : 110-112

Informa Healthcare

Access to resources Recommend Favorite

A Cancer Research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen

By Johnston S.   Gumbrell L.   Evans T.   Coleman R.   Smith I.   Twelves C.   Soukop M.   Rea D.   Earl H.   Howell A.   Jones A.   Canney P.   Powles T.   Haynes B.   Nutley B.   Grimshaw R.   Jarman M.   Halbert G.   Brampton M.   Haviland J.   Dowsett M.   Coombes R.  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 4, 2004-04 ,pp. : 341-348

Springer Publishing Company

Access to resources Recommend Favorite

Impact of prophylactic pyridoxine on occurrence of hand–foot syndrome in patients receiving capecitabine for advanced or metastatic breast cancer

By Yoshimoto Nobuyasu  

Breast Cancer, Vol. 17, Iss. 4, 2010-10 ,pp. : 298-302

Springer Publishing Company

Access to resources Recommend Favorite

Locally Advanced Non-metastatic Breast Cancer: Analysis of Prognostic Factors in 125 Patients Homogeneously Treated with a Combined Modality Approach

By Gardin G.   Rosso R.   Campora E.   Repetto L.   Naso C.   Canavese G.   Catturich A.   Corvo R.   Guenzi M.   Pronzato P.   Baldini E.   Conte P.F.  

European Journal of Cancer, Vol. 31, Iss. 9, 1995-09 ,pp. : 1428-1433

Elsevier

Access to resources Recommend Favorite